Other Assets, Noncurrent in USD of PLUS THERAPEUTICS, INC. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
PLUS THERAPEUTICS, INC. quarterly Other Assets, Noncurrent history and change rate from Q4 2010 to Q3 2025.
  • PLUS THERAPEUTICS, INC. Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $45K, a 40.6% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

PLUS THERAPEUTICS, INC. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $45K +$13K +40.6% 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $45K +$13K +40.6% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $19K -$13K -40.6% 31 Mar 2025 10-Q 30 May 2025
Q4 2024 $12K -$20K -62.5% 31 Dec 2024 10-Q 30 Oct 2025
Q3 2024 $32K $0 0% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $32K +$20K +167% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $32K +$20K +167% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $32K +$20K +167% 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 $32K +$20K +167% 30 Sep 2023 10-Q 31 Oct 2023
Q2 2023 $12K -$4K -25% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $12K -$4K -25% 31 Mar 2023 10-Q 20 Apr 2023
Q4 2022 $12K -$4K -25% 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 $12K -$4K -25% 30 Sep 2022 10-Q 20 Oct 2022
Q2 2022 $16K $0 0% 30 Jun 2022 10-Q 21 Jul 2022
Q1 2022 $16K $0 0% 31 Mar 2022 10-Q 21 Apr 2022
Q4 2021 $16K $0 0% 31 Dec 2021 10-K 23 Feb 2023
Q3 2021 $16K -$2K -11.1% 30 Sep 2021 10-Q 21 Oct 2021
Q2 2021 $16K -$2K -11.1% 30 Jun 2021 10-Q 22 Jul 2021
Q1 2021 $16K -$42K -72.4% 31 Mar 2021 10-Q 22 Apr 2021
Q4 2020 $16K -$56K -77.8% 31 Dec 2020 10-K 24 Feb 2022
Q3 2020 $18K -$34K -65.4% 30 Sep 2020 10-Q 22 Oct 2020
Q2 2020 $18K -$32K -64% 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 $58K +$18K +45% 31 Mar 2020 10-Q 14 May 2020
Q4 2019 $72K +$33K +84.6% 31 Dec 2019 10-K 22 Feb 2021
Q3 2019 $52K -$1.89M -97.3% 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 $50K -$2M -97.6% 30 Jun 2019 10-Q 15 Aug 2019
Q1 2019 $40K -$2.14M -98.2% 31 Mar 2019 8-K 10 Sep 2019
Q4 2018 $39K -$3K -7.14% 31 Dec 2018 10-K 30 Mar 2020
Q3 2018 $1.94M +$84K +4.53% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 $2.05M +$336K +19.6% 30 Jun 2018 10-Q 14 Aug 2018
Q1 2018 $2.18M +$174K +8.67% 31 Mar 2018 10-Q 11 May 2018
Q4 2017 $42K -$2.29M -98.2% 31 Dec 2017 8-K 10 Sep 2019
Q3 2017 $1.85M +$380K +25.8% 30 Sep 2017 10-Q 09 Nov 2017
Q2 2017 $1.71M +$263K +18.2% 30 Jun 2017 10-Q 11 Aug 2017
Q1 2017 $2.01M +$326K +19.4% 31 Mar 2017 10-Q 12 May 2017
Q4 2016 $2.34M +$815K +53.6% 31 Dec 2016 10-K 09 Mar 2018
Q3 2016 $1.47M +$260K +21.4% 30 Sep 2016 10-Q 09 Nov 2016
Q2 2016 $1.45M -$31K -2.1% 30 Jun 2016 10-Q 05 Aug 2016
Q1 2016 $1.68M -$103K -5.77% 31 Mar 2016 10-Q 10 May 2016
Q4 2015 $1.52M -$242K -13.7% 31 Dec 2015 10-K 24 Mar 2017
Q3 2015 $1.21M -$1.08M -47% 30 Sep 2015 10-Q 06 Nov 2015
Q2 2015 $1.48M -$1.09M -42.3% 30 Jun 2015 10-Q 10 Aug 2015
Q1 2015 $1.79M -$627K -26% 31 Mar 2015 10-Q 11 May 2015
Q4 2014 $1.76M -$1.05M -37.3% 31 Dec 2014 10-K 11 Mar 2016
Q3 2014 $2.29M +$329K +16.8% 30 Sep 2014 10-Q 07 Nov 2014
Q2 2014 $2.57M +$119K +4.86% 30 Jun 2014 10-Q 11 Aug 2014
Q1 2014 $2.41M -$396K -14.1% 31 Mar 2014 10-Q 12 May 2014
Q4 2013 $2.81M +$72K +2.63% 31 Dec 2013 10-K 16 Mar 2015
Q3 2013 $1.96M +$206K +11.7% 30 Sep 2013 10-Q 12 Nov 2013
Q2 2013 $2.45M +$693K +39.5% 30 Jun 2013 10-Q 09 Aug 2013
Q1 2013 $2.81M +$1.01M +56.5% 31 Mar 2013 10-Q 10 May 2013
Q4 2012 $2.74M +$968K +54.6% 31 Dec 2012 10-K 14 Mar 2014
Q3 2012 $1.76M +$426K +32% 30 Sep 2012 10-Q 09 Nov 2012
Q2 2012 $1.76M +$284K +19.3% 30 Jun 2012 10-Q 09 Aug 2012
Q1 2012 $1.79M 31 Mar 2012 10-Q 10 May 2012
Q4 2011 $1.77M +$1.21M +213% 31 Dec 2011 10-K 15 Mar 2013
Q3 2011 $1.33M 30 Sep 2011 10-Q 08 Nov 2011
Q2 2011 $1.47M 30 Jun 2011 10-Q 09 Aug 2011
Q4 2010 $566K 31 Dec 2010 10-K/A 07 Sep 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.